COMPANY

Grace Therapeutics

gracetx.com ↗ · Mid-Atlantic

Keywords: rare disease ataxia telangiectasia

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Private placement · about $10M · announced Aug 4, 2026 Company release ↗
Source quote
- Aug 4, 2026 · Company release ↗
  “The financing is expected to result in aggregate gross proceeds to the Company of approximately $10 million, before deducting placement agent fees and other offering expenses”

From the company’s own releases; this list is partial. All raises and deals

Aug 4, 2026 Raise Private placement: $10M (total, as published), announced Aug 4, 2026. Source: SEC filing. source ↗ · Form D filed Aug 11, 2026 SEC Form D ↗
Aug 4, 2026 Raise Private placement · about $10M source ↗
Feb 10, 2025 Raise Private placement: $15M (total, as published), announced Feb 10, 2025. Source: SEC filing. source ↗

Raised: $25.0M. Last 2 years.

Aug 4, 2026 Private placement: $10M (total, as published), announced Aug 4, 2026. Source: SEC filing. source ↗ · Form D filed Aug 11, 2026 SEC Form D ↗
Feb 10, 2025 Private placement: $15M (total, as published), announced Feb 10, 2025. Source: SEC filing. source ↗

Form D raises come from the company’s own SEC filing (last 2 years).

2026-08-11 Raise Private raise (SEC Form D): $10.0M sold; issuer “Grace Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗
2025-02-25 Raise Private raise (SEC Form D): $15.0M sold of $30.0M offered; issuer “Grace Therapeutics, Inc.”. Verified from the SEC filing. SEC filing ↗